Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Harrow Health Q1 2024 Adj EPS $(0.28) Misses $(0.20) Estimate, Sales $34.600M Miss $37.268M Estimate

Author: Benzinga Newsdesk | May 13, 2024 04:04pm

Harrow Health (NASDAQ:HROW) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.20) by 40 percent. The company reported quarterly sales of $34.600 million which missed the analyst consensus estimate of $37.268 million by 7.16 percent. This is a 32.55 percent increase over sales of $26.103 million the same period last year.

Posted In: HROW